drug

Cancer drug company accuses U.S. market makers of stock usurpation

Cancer drug company accuses U.S. market makers of stock usurpation

A cancer-focused biotech company has sued eight of America’s biggest traders, including Citadel Securities, Susquehanna and Virtu, alleging they deliberately depressed its stock price by placing sell orders they didn’t have not intend to perform. The lawsuit, filed Thursday by Northwest Biotherapeutics in federal court in New York, alleged that marketers “deliberately engaged in repeated …

Cancer drug company accuses U.S. market makers of stock usurpation Read More »

Roche's Alzheimer's drug fails in long-awaited trial

Roche’s Alzheimer’s drug fails in long-awaited trial

Trials show small benefit, but without statistical validity Roche setback leaves Biogen and Eisai as leaders in the field It’s up to Roche’s CEO-designate to revive development fortunes Roche shares down 3.4%, its development partner Morphosys down 29% Nov 14 (Reuters) – Roche’s (ROG.S) drug candidate for Alzheimer’s disease has not been shown to slow …

Roche’s Alzheimer’s drug fails in long-awaited trial Read More »